| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 3, 2024 |
| Accession Number: | 0001493152-24-025823 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
6-K - Femto Technologies Inc. (0001888151) (Filer)
6-K - Femto Technologies Inc. (0001888151) (Filer)
6-K - Femto Technologies Inc. (0001888151) (Filer)
NEW YORK, NY / ACCESSWIRE / March 18, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $7.0 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN).About BYND Cannasoft Enterprises Inc.BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel. The company owns and markets Benefit CRM, a customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, personnel management, marketing, call centre, and asset management activities; and develops New Cannabis CRM platf
ASHKELON, Israel and VANCOUVER, British Columbia, Jan. 25, 2024 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") announced today that its EZ-G project team has arrived in Shenzhen, China to sign agreements with two of the largest manufacturers in the province to begin production of the EZ-G device and EZ-G Capsules. BYND Cannasoft intends to start mass production of its EZ-G device and EZ-G capsules after the Chinese New Year which ends on February 24, 2024. Starting production of the EZ-G device and EZ-G capsules will allow BYND Cannasoft to meet its benchmark of starting the sale of the EZ-G device and EZ-G capsules in the s
NEW YORK, NY / ACCESSWIRE / December 21, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN).About BYND Cannasoft Enterprises Inc.BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel. The company owns and markets Benefit CRM, a customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, personnel management, marketing, call centre, and asset management activities; and develops New Cannabi
VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 24, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") announced today that it entered into a consulting service with Matrix Medika, a developer of medical systems specialized in assisting companies in obtaining regulatory approval for medical devices under development. The service will be given as part of the agreement with Arkit Studio, a company that provides the service of characterization and design for the EZ-G Device. Matrix Medika will assist BYND Cannasoft by granting expert opinion and market research about the regulatory approval process for the Company's EZ
SC 13G/A - Femto Technologies Inc. (0001888151) (Subject)
SC 13D - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)
SC 13G - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)